These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 19793175

  • 41. Effects of lotus root (the edible rhizome of Nelumbo nucifera) on the deveolopment of non-alcoholic fatty liver disease in obese diabetic db/db mice.
    Tsuruta Y, Nagao K, Shirouchi B, Nomura S, Tsuge K, Koganemaru K, Yanagita T.
    Biosci Biotechnol Biochem; 2012; 76(3):462-6. PubMed ID: 22451385
    [Abstract] [Full Text] [Related]

  • 42. Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis.
    Liu R, Pan X, Whitington PF.
    Liver Int; 2009 Mar; 29(3):337-43. PubMed ID: 18710424
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.
    Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM.
    Hepatology; 2003 Feb; 37(2):343-50. PubMed ID: 12540784
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice.
    Nagao K, Inoue N, Inafuku M, Shirouchi B, Morooka T, Nomura S, Nagamori N, Yanagita T.
    J Nutr Biochem; 2010 May; 21(5):418-23. PubMed ID: 19423319
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Glycine prevents metabolic steatohepatitis in diabetic KK-Ay mice through modulation of hepatic innate immunity.
    Takashima S, Ikejima K, Arai K, Yokokawa J, Kon K, Yamashina S, Watanabe S.
    Am J Physiol Gastrointest Liver Physiol; 2016 Dec 01; 311(6):G1105-G1113. PubMed ID: 27659424
    [Abstract] [Full Text] [Related]

  • 50. Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice.
    Haub S, Ritze Y, Ladel I, Saum K, Hubert A, Spruss A, Trautwein C, Bischoff SC.
    J Pharmacol Exp Ther; 2011 Dec 01; 339(3):790-8. PubMed ID: 21903748
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Hepatic overexpression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms.
    Jiang M, He J, Kucera H, Gaikwad NW, Zhang B, Xu M, O'Doherty RM, Selcer KW, Xie W.
    J Biol Chem; 2014 Mar 21; 289(12):8086-97. PubMed ID: 24497646
    [Abstract] [Full Text] [Related]

  • 54. Morphological characterization of systemic changes in KK-Ay mice as an animal model of type 2 diabetes.
    Moroki T, Yoshikawa Y, Yoshizawa K, Tsubura A, Yasui H.
    In Vivo; 2013 Mar 21; 27(4):465-72. PubMed ID: 23812216
    [Abstract] [Full Text] [Related]

  • 55. Hepatic ALT isoenzymes are elevated in gluconeogenic conditions including diabetes and suppressed by insulin at the protein level.
    Qian K, Zhong S, Xie K, Yu D, Yang R, Gong DW.
    Diabetes Metab Res Rev; 2015 Sep 21; 31(6):562-71. PubMed ID: 25865565
    [Abstract] [Full Text] [Related]

  • 56. Regulation of TNFα converting enzyme activity in visceral adipose tissue of obese mice.
    Kawasaki S, Motoshima H, Hanatani S, Takaki Y, Igata M, Tsutsumi A, Matsumura T, Kondo T, Senokuchi T, Ishii N, Kinoshita H, Fukuda K, Kawashima J, Shimoda S, Nishikawa T, Araki E.
    Biochem Biophys Res Commun; 2013 Jan 25; 430(4):1189-94. PubMed ID: 23274494
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice.
    Shimizu M, Yasuda Y, Sakai H, Kubota M, Terakura D, Baba A, Ohno T, Kochi T, Tsurumi H, Tanaka T, Moriwaki H.
    BMC Cancer; 2011 Jun 28; 11():281. PubMed ID: 21711565
    [Abstract] [Full Text] [Related]

  • 60. Alteration of hepatic but not renal transporter expression in diet-induced obese mice.
    More VR, Slitt AL.
    Drug Metab Dispos; 2011 Jun 28; 39(6):992-9. PubMed ID: 21430232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.